|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |
ABSTRACT |
|---|
|
|
|---|
"High-probability" ventilation/perfusion (
/
) lung scans generally indicate proximal pulmonary arterial occlusion by thromboemboli or, rarely, other processes such as tumors, fibrosing mediastinitis, or vasculitis. In this report we describe three patients with high
probability
/
scans in whom pulmonary angiography failed to
demonstrate arterial occlusion. All three patients were determined to have pulmonary venoocclusive disease (PVOD). In two patients, a tissue diagnosis of PVOD was made, in one case with explanted tissue taken after a successful heart-lung transplant and in the other case with tissue taken at autopsy. PVOD in the third patient was diagnosed with pulmonary venography. A potential explanation for the discrepancy between perfusion lung scan and pulmonary angiographic findings in PVOD is discussed.
| |
INTRODUCTION |
|---|
|
|
|---|
Ventilation/perfusion (
/
) lung scanning is an integral part
of the evaluation of a patient with pulmonary hypertension (1). Multiple segmental perfusion defects usually indicate proximal thromboemboli as the cause of pulmonary hypertension (2). Rarely, a "high-probability"
/
scan is caused by
other processes obstructing the pulmonary arterial tree, such
as fibrosing mediastinitis, pulmonary artery sarcoma, and vasculitis (3). In all of these processes, pulmonary arteriography and chest computed tomography (CT) will confirm the
presence of proximal obstructing lesions.
In this paper we describe three patients in whom marked
discrepancies were noted between findings on
/
scans and
those in pulmonary arteriograms. Two of three patients had
biopsy-proven pulmonary venoocclusive disease (PVOD) as
the cause of pulmonary hypertension; the other patient had
PVOD diagnosed by pulmonary venography. These cases emphasize the importance of considering alternative causes for a
high-probability
/
scan when pulmonary angiography fails
to disclose evidence of pulmonary thromboembolism.
| |
CASE REPORT |
|---|
|
|
|---|
Patient 1
A 47-yr-old male had been well until 1 yr before referral,
when he presented with rapidly worsening dyspnea. As part of
his initial evaluation, he underwent a
/
scan that revealed
multiple mismatched segmental perfusion defects. An open-lung biopsy was performed because of progressive pulmonary
infiltrates, and demonstrated pulmonary arteriopathy with
tortuous, dilated pulmonary veins. Upon referral, the patient
underwent a repeat
/
scan, which confirmed multiple mismatched segmental perfusion defects involving the right upper
lobe, right lower lobe, lingula, and part of the left lower lobe
(Figure 1). Cardiac catheterization disclosed a right atrial pressure (Pra) of 6 mm Hg and a pulmonary artery pressure (Ppa)
of 85/35 mm Hg (mean: 60 mm Hg). The pulmonary capillary
wedge pressure (Ppcw) was 8 mm Hg and 12 mm Hg in the right and left pulmonary arteries, respectively. The cardiac
output (CO) was 5.0 L/min, and the pulmonary vascular resistance (Rpv) was 832 dynes · s/cm5. Pulmonary angiography,
done according to standard technique with separate injections
of 55 to 60 ml of contrast medium into each main pulmonary
artery, showed smoothly tapering major branches, with peripheral pruning bilaterally (Figures 2A and 2B). In the late
phase of the pulmonary arteriogram, the pulmonary veins
were extremely narrowed throughout their course. A spiral
CT revealed increased interstitial markings, a small left pleural effusion, thickening of the interlobar septa, and attenuated
pulmonary veins bilaterally. The patient subsequently underwent heart-lung transplantation. Histologic examination of
explanted tissue was diagnostic for PVOD.
|
|
Patient 2
A 34-yr-old man with a history of mild systemic hypertension
was in good health until 4 mo before admission, when he developed dyspnea on exertion of insidious onset. The dyspnea
progressed rapidly and the patient was admitted to a local hospital, where he was found to have evidence of pulmonary hypertension on echocardiography and segmental mismatched
perfusion defects on
/
scanning. Over the following 2 mo
the patient's condition deteriorated rapidly and he was referred
to this center for evaluation for pulmonary thromboendarterectomy. A repeat
/
scan was remarkable for multiple segmental and subsegmental mismatched perfusion defects involving both lungs (Figure 3). A chest CT showed a mosaic
perfusion pattern, eccentric pleural thickening, prominent hilar and mediastinal lymphadenopathy, and marked enlargement of the central pulmonary arteries. Cardiac catheterization showed a Pra of 4 mm Hg, Ppa of 90/34 mm Hg (mean: 57 mm Hg), Ppcw of 5 mm Hg, cardiac index (CI) of 3.2 L/min/m2,
and Rpv of 1,291 dynes · s/cm5. No intracardiac shunt or anomalous pulmonary venous return was detected. Pulmonary
angiography showed enlarged central pulmonary arteries and
pruning of the vessels distally (Figures 4A and 4B). No thromboemboli were detected on angiography or angioscopy. Inhaled NO at 20 ppm was given for 10 min, and repeat hemodynamics showed a Pra of 0 mm Hg, Ppa of 57/24 mm Hg (mean:
38 mm Hg), Ppcw of 7 mm Hg, CI of 2.7 L/min/m2, and Rpv of
917 dynes · s/cm5. Over the following several days, the patient
became increasingly hypoxemic and ultimately expired from
cardiac failure. The results of autopsy confirmed the diagnosis
of PVOD.
|
|
Patient 3
A 38-yr-old woman with a history of hypothyroidism was well
until 5 yr before presentation to our center, when she developed dyspnea during a pregnancy and was treated for a presumptive pulmonary embolism. Three years later she noted
worsening exertional dyspnea. Further evaluation at that time
included a cardiac catheterization showing moderate pulmonary
hypertension and pulmonary angiography showing no evidence
of proximal thromboemboli. She had an acute pulmonary vasodilator response to 20 ppm of inhaled NO and subsequently began treatment with diltiazem. Over the next several months
her dyspnea and hypoxemia worsened, and she was referred
to our center for evaluation for possible pulmonary thromboendarterectomy. A
/
scan was remarkable for multiple
segmental and subsegmental mismatched perfusion defects,
most prominent in the right upper lobe and bilateral bases
(Figure 5). Cardiac catheterization showed a Pra of 2 mm Hg,
Ppa of 47/20 mm Hg (mean: 26 mm Hg), Ppcw of 7 mm Hg,
CO of 5.34 L/min, and Rpv of 284 dynes · s/cm5. With exercise,
the Ppa increased to 80/33 mm Hg (mean: 50 mm Hg). The
Ppcw was 10 mm Hg, the Rpv was 334 dynes · s/cm5, and the
CO was 9.58 L/min. Pulmonary angiography revealed significant peripheral pruning of the left-sided vessels and a minor
irregularity at the takeoff of the right middle-lobe vessel, but
no evidence of pulmonary thromboemboli (Figures 6A and
6B). Pulmonary angioscopy confirmed the absence of thromboembolic disease. A chest CT showed a mosaic pattern of
lung attenuation, enlarged central pulmonary arteries, areas of
ground-glass opacity, and mediastinal adenopathy. On the basis of these results the patient was given a presumptive diagnosis of PVOD. Chronic inhaled NO therapy was begun, and the patient is doing well 2 yr after discharge. A pulmonary venogram performed during this 2-yr period showed several sites of
stenosis in the pulmonary veins. Balloon dilatation of several
of these stenoses reduced the patient's dyspnea.
|
|
| |
DISCUSSION |
|---|
|
|
|---|
In this report we describe three patients with pulmonary hypertension and high-probability
/
scans resulting from
PVOD. PVOD is a rare but increasingly recognized cause of
pulmonary hypertension (6). The prognosis in PVOD is usually
poor, with severe, progressive pulmonary hypertension and
right ventricular failure usually occurring within 2 yr of diagnosis (7). Options for medical therapy other than lung transplantation have been disappointing. Intravenous epoprostenol,
which has clear efficacy in primary pulmonary hypertension
(PPH), has been reported to cause acute pulmonary edema
and even death in patients with PVOD. Oral nifedipine, high-dose prostacyclin, inhaled NO, and aerosolized iloprost have
been described as having beneficial hemodynamic effects in
some patients (8). Distinguishing PVOD from both PPH
and chronic thromboembolic disease, a surgically curable form of pulmonary hypertension (11, 12), is therefore critical.
Chest radiographic findings in PVOD include enlargement of the right side of the heart, dilated central pulmonary arteries, pleural effusions, and signs of pulmonary edema with bilateral increased interstitial markings and Kerley B lines (13, 14). Mediastinal adenopathy caused by vascular congestion may also be seen (15). Swensen and colleagues described common chest CT findings in eight patients with PVOD, which included smooth interlobular septal thickening, diffuse multifocal regions of ground-glass opacity, pleural effusions, a dilated main pulmonary artery and central pulmonary arteries, pulmonary veins of normal caliber, and a mosaic pattern of lung attenuation (16). Pulmonary angiography has been described as showing dilated patent pulmonary arteries, a prolonged circulation time, and a normal left atrium and pulmonary veins (13).
/
lung scanning plays a pivotal role in the diagnostic approach to patients with pulmonary hypertension. In PPH (and
other forms of small-vessel pulmonary hypertension),
/
scans
are characteristically normal or may demonstrate a mottled appearance (17). In chronic thromboembolic pulmonary hypertension, segmental or larger perfusion defects are invariably
present. In addition to thromboembolism, processes including
pulmonary artery sarcoma, vasculitis, and extrinsic compression
by mediastinal adenopathy or fibrosis will cause obstruction of
segmental or larger arteries and lead to a high-probability
/
scan. Pulmonary angiography in these cases will confirm occlusion or extrinisic compression of the pulmonary arterial branches.
In PVOD,
/
scans are frequently reported to be normal
(13). Other reported findings have included diffuse, patchy
distribution of tracer material without clear segmental or subsegmental defects, and unilateral absence of perfusion due to
severe asymmetric involvement of the major pulmonary veins
(17). To our knowledge, this is the first report of multiple
segmental mismatched perfusion defects with negative pulmonary angiograms in patients with PVOD.
In the third case, in which lung biopsy was not performed, the diagnosis of PVOD was initially suggested on clinical grounds. This patient's chest CT had several findings reported to be consistent with the diagnosis of PVOD, including a mosaic pattern of lung attenuation, enlarged central pulmonary arteries, areas of smooth interlobular septal thickening, and mediastinal adenopathy (16, 20). In addition, the pulmonary venogram demonstrated focal venous obstructions, a finding highly suggestive of the diagnosis of PVOD. The patient in this case has been treated with chronic inhaled NO for 2 yr, and has continued to do well.
Other potential causes of pulmonary venous obstruction
that could result in the abnormalities observed in the
/
scan
in the third case include extrinsic compression of the pulmonary veins or pulmonary capillary hemangiomatosis (PCH)
(21). Although PCH could not be definitively ruled out in this
case without histologic examination of lung tissue, extrinsic
compression of the pulmonary veins was excluded by chest CT.
One hypothesis that could explain the discordance between
the findings in the
/
scan and pulmonary angiogram in
PVOD relates to the increased downstream resistance caused
by the narrowing and obliteration of pulmonary veins and
venules. Since the distribution of particles in the lungs is proportional to regional pulmonary blood flow, high downstream
resistance could reduce tracer deposition in the precapillary
arterioles upstream of the venous occlusion, resulting in a mismatched perfusion defect in the
/
scan. That these areas
fail to demonstrate corresponding defects in the pulmonary
angiogram could be explained by the higher pressure used in
injecting contrast medium into the pulmonary arteries, which
would overcome the increased downstream resistance.
Why some cases of PVOD show this
/
scan abnormality
while others do not is unclear. Perhaps disease resulting in
more extensive involvement of larger veins leads to segmental
defects, whereas diffuse involvement of smaller venules produces the more frequently described
/
scan abnormality of
diffuse patchy distribution of tracer material. This hypothesis
is supported by the findings on pulmonary venography described in the third case, with extensive involvement of larger veins.
We found one report of unilateral absence of perfusion associated with stenosis involving the main pulmonary veins in PVOD (19). In contrast to our patients, this patient did not undergo pulmonary angiography, and pulmonary artery embolic disease could therefore not be excluded.
The findings in this report have important clinical implications. Systemic vasodilators such as prostacyclin have been reported to cause pulmonary edema and even death in patients
with PVOD (22, 23). Therefore, a high index of suspicion for
PVOD should be present when a discrepancy exists between
the
/
scan and pulmonary angiogram.
In conclusion, a high-probability
/
scan in a patient with
pulmonary hypertension does not always indicate a proximal pulmonary arterial process; when coupled with an angiogram
showing no arterial obstruction, this finding is probably due to
a focal "downstream" process such as PVOD.
| |
Footnotes |
|---|
Correspondence and requests for reprints should be addressed to Richard N. Channick, M.D., UCSD Medical Center, 9300 Campus Point Drive, San Diego, CA 92103-7381.
(Received in original form March 8, 2000 and in revised form June 11, 2000).
Acknowledgments: The authors thank Eunhee S. Yi, M.D., of the Department of Pathology, University of California at San Diego Medical Center, for assistance with the pathologic material in the cases described in this report.
Supported in part by Pulmonary Training Grant 5T34HL0722-24 from the National Institutes of Health.
| |
References |
|---|
|
|
|---|
1.
Rubin LJ.
Approach to the diagnosis and treatment of pulmonary hypertension.
Chest
1989;
96:
659-664
2.
McNeil BJ.
A diagnostic strategy using ventilation-perfusion studies in
patients suspect for pulmonary embolism.
J Nucl Med
1976;
17:
613-616
3.
Berry DF,
Buccigrossi D,
Peabody J,
Peterson KL,
Moser KM.
Pulmonary vascular occlusion and fibrosing mediastinitis.
Chest
1986;
89:
296-301
4.
Myerson PJ,
Myerson DA,
Katz R,
Lawson JP.
Gallium imaging in pulmonary artery sarcoma mimicking pulmonary embolism: case report.
J Nucl Med
1976;
17:
893-895
5. Kerr KM, Auger WR, Fedullo PF, Channick RN, Yi ES, Moser KM. Large vessel pulmonary arteritis mimicking chronic thromboembolic disease. Am J Respir Crit Care Med 1995; 152: 367-373 [Abstract].
6. Rich S, Dantzker DR, Ayres SM, Bergofsky EH, Brundage BH, Detre KM, Fishman AP, Goldring RM, Groves BM, Koerner SK, et al . . Primary pulmonary hypertension: a national prospective study. Ann Intern Med 1987; 107: 216-223 .
7.
Pietra GG,
Edwards WD,
Kay JM,
Rich S,
Kernis J,
Schloo B,
Ayres SM,
Bergofsky EH,
Brundage BH,
Detre KM, et al
.
. Histopathology of
primary pulmonary hypertension: a qualitative and quantitative study
of pulmonary blood vessels from 58 patients in the National Heart,
Lung, and Blood Institute, primary pulmonary hypertension registry.
Circulation
1989;
80:
1198-1206
8.
Salzman GA,
Rosa UW.
Prolonged survival in pulmonary veno-occlusive disease treated with nifedipine.
Chest
1989;
95:
1154-1156
9.
Davis LL,
deBoisblanc BP,
Glynn CE,
Ramirez C,
Summer WR.
Effect
of prostacyclin on microvascular pressures in a patient with pulmonary veno-occlusive disease.
Chest
1995;
108:
1754-1756
10. Hoeper MM, Eschenbruch C, Zink-Wohlfart C, Schulz A, Markworth S, Pohl K, Fabel H. Effects of inhaled nitric oxide and aerosolized iloprost in pulmonary veno-occlusive disease. Respir Med 1999; 93: 62-70 [Medline].
11. Moser KM, Auger WR, Fedullo PF, Jamieson SW. Chronic thromboembolic pulmonary hypertension: clinical picture and surgical treatment. Eur Respir J 1992; 5: 334-342 [Abstract].
12. Rubin LJ. Primary pulmonary hypertension. Chest 1993; 104: 235-250 .
13. Scheibel R, Dedeker K, Gleason D, Pliego M, Kieffer SA. Radiographic and angiographic characteristics of pulmonary veno-occlusive disease. Radiology 1972; 103: 47-51 [Medline].
14.
Wagenvoort CA.
Pulmonary veno-occlusive disease: entity or syndrome?
Chest
1976;
69:
82-86
15. Veeraraghavan S, Koss MN, Sharma OP. Pulmonary veno-occlusive disease. Curr Opin Pulm Med 1999; 5: 310-313 . [Medline]
16.
Swensen SJ,
Tashjian JH,
Myers JL,
Engeler CE,
Patz EF,
Edwards WD,
Douglas WW.
Pulmonary venoocclusive disease.
AJR Am J Roentgenol
1999;
167:
937-940
17. Rich S, Giuseppe G, Pietra MD, Kieras K, Hart K, Brundage BH. Primary pulmonary hypertension: radiographic and scintigraphic patterns of histologic subtypes. Ann Intern Med 1986; 105: 499-502 .
18. Sola M, Garcia A, Picado C, Ramirez J, Plaza V, Herranz R. Segmental contour pattern in a case of pulmonary venoocclusive disease. Clin Nucl Med 1993; 18: 679-681 [Medline].
19.
Calderon M,
Burdine JA.
Pulmonary veno-occlusive disease.
J Nucl
Med
1973;
15:
455-457
20.
Dufour B,
Maitre S,
Humbert M,
Capron F,
Simonneau G,
Musset D.
High-resolution CT of the chest in four patients with pulmonary capillary hemangiomatosis or pulmonary venoocclusive disease.
AJR Am J
Roentgenol
1998;
171:
1321-1324
21. Tron V, Magee F, Wright JL, Colby T, Churg A. Pulmonary capillary hemangiomatosis. Hum Pathol 1986; 17: 1144-1150 [Medline].
22. Rubin LJ, Mendoza M, Hood M, McGoon M, Barst R, Williams W, Diehl JH, Crow J, Long W. Treatment of pulmonary hypertension with continuous intravenous prostacyclin (epoprostenol): results of a randomized trial. Ann Intern Med 1990; 112: 485-491 .
23.
Palmer SM,
Robinson LJ,
Wang A,
Gossage JR,
Bashore T,
Tapson VF.
Massive pulmonary edema and death after prostacyclin infusion in a
patient with pulmonary veno-occlusive disease.
Chest
1998;
113:
237-240
This article has been cited by other articles:
![]() |
A. A. Frazier, T. J. Franks, T.-L. H. Mohammed, I. H. Ozbudak, and J. R. Galvin From the Archives of the AFIP: Pulmonary Veno-occlusive Disease and Pulmonary Capillary Hemangiomatosis RadioGraphics, May 1, 2007; 27(3): 867 - 882. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Coulden State-of-the-Art Imaging Techniques in Chronic Thromboembolic Pulmonary Hypertension Proceedings of the ATS, September 1, 2006; 3(7): 577 - 583. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Hoeper, E. Mayer, G. Simonneau, and L. J. Rubin Chronic Thromboembolic Pulmonary Hypertension Circulation, April 25, 2006; 113(16): 2011 - 2020. [Full Text] [PDF] |
||||
![]() |
L. J. Rubin and D. B. Badesch Evaluation and Management of the Patient with Pulmonary Arterial Hypertension Ann Intern Med, August 16, 2005; 143(4): 282 - 292. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. McGoon, D. Gutterman, V. Steen, R. Barst, D. C. McCrory, T. A. Fortin, and J. E. Loyd Screening, Early Detection, and Diagnosis of Pulmonary Arterial Hypertension: ACCP Evidence-Based Clinical Practice Guidelines Chest, July 1, 2004; 126(1_suppl): 14S - 34S. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. F. Fedullo, W. R. Auger, K. M. Kerr, and L. J. Rubin Chronic Thromboembolic Pulmonary Hypertension N. Engl. J. Med., November 15, 2001; 345(20): 1465 - 1472. [Full Text] [PDF] |
||||
![]() |
M. J. TOBIN Chronic Obstructive Pulmonary Disease, Pollution, Pulmonary Vascular Disease, Transplantation, Pleural Disease, and Lung Cancer in AJRCCM 2000 Am. J. Respir. Crit. Care Med., November 15, 2001; 164(10): 1789 - 1804. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Proc. Am. Thorac. Soc. | Am. J. Respir. Cell Mol. Biol. |